Assembly Biosciences, Inc. (ASMB)

Assembly Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	28.45	19.84	52.42	45.63	59.44	46.73
Short-Term Investments	66.5	110.41	39.19	101	156.97	227.31
Cash & Short-Term Investments	94.95	130.25	91.61	146.63	216.41	274.04
Cash Growth	105.48%	42.18%	-37.52%	-32.25%	-21.03%	25.66%
Accounts Receivable	-	0.04	0.94	0.34	1.23	3.37
Other Receivables	0.4	0.3	0.3	-	-	-
Receivables	0.4	0.34	1.24	0.34	1.23	3.37
Prepaid Expenses	2.86	3.2	4.11	7.24	6.85	5.36
Total Current Assets	98.21	133.79	96.97	154.2	224.49	282.78
Property, Plant & Equipment	1.74	2.72	3.94	7.18	10.73	13.81
Long-Term Investments	-	-	-	27.97	-	-
Goodwill	-	-	-	-	12.64	12.64
Other Intangible Assets	-	-	-	-	29	29
Long-Term Deferred Charges	-	-	0.2	0.2	0.8	-
Other Long-Term Assets	0.31	0.31	0.69	1.5	5.59	1.68
Total Assets	100.26	136.82	101.79	191.06	283.25	339.91
Accounts Payable	1.34	0.46	2.49	2.66	4.6	1.73
Accrued Expenses	6.35	6.63	9.84	10.26	12.27	11.02
Current Portion of Leases	1.33	1.22	3.36	3.15	3.4	3.19
Current Unearned Revenue	32.62	30.92	-	-	-	6.41
Other Current Liabilities	-	-	0.6	-	4.16	2.09
Total Current Liabilities	41.64	39.23	16.3	16.07	24.43	24.44
Long-Term Leases	0.11	1.12	0.1	3.33	6.73	9.08
Long-Term Unearned Revenue	32.51	55.38	2.73	2.73	8.99	30.64
Long-Term Deferred Tax Liabilities	-	-	-	-	2.53	2.53
Total Liabilities	74.26	95.73	19.13	22.13	42.68	66.69
Common Stock	0.01	0.01	0	0.05	0.03	0.03
Additional Paid-In Capital	841.74	826.92	807.98	800.73	742.39	712.81
Retained Earnings	-815.59	-785.75	-724.52	-631.43	-501.57	-439.42
Comprehensive Income & Other	-0.16	-0.08	-0.8	-0.42	-0.27	-0.2
Total Common Equity	26	41.1	82.66	168.93	240.58	273.22
Shareholders' Equity	26	41.1	82.66	168.93	240.58	273.22
Total Liabilities & Equity	100.26	136.82	101.79	191.06	283.25	339.91
Total Debt	1.44	2.34	3.47	6.48	10.13	12.27
Net Cash (Debt)	93.51	127.91	88.15	168.12	206.28	261.78
Net Cash Growth	106.47%	45.11%	-47.57%	-18.50%	-21.20%	20.04%
Net Cash Per Share	16.40	27.94	21.85	46.61	69.87	119.63
Filing Date Shares Outstanding	6.36	5.48	4.33	4.01	3.19	2.72
Total Common Shares Outstanding	6.35	5.48	4.07	4.01	2.84	2.71
Working Capital	56.58	94.56	80.67	138.13	200.06	258.34
Book Value Per Share	4.09	7.50	20.29	42.13	84.84	100.70
Tangible Book Value	26	41.1	82.66	168.93	198.94	231.58
Tangible Book Value Per Share	4.09	7.50	20.29	42.13	70.16	85.35
Machinery	-	0.53	0.8	0.72	0.95	0.95
Leasehold Improvements	-	0.06	1.63	1.63	2.49	2.08

Source: S&P Capital IQ. Standard template. Financial Sources.